Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tmanke
    Member
    • Oct 2009
    • 26

    #1

    Bioinformatics Postdoc @ MPI of Immunobiology and Epigenetics, Freiburg, Germany

    The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany, invites applications for a

    Postdoctoral Position in Bioinformatics

    which is available immediately for an initial period of two years.

    Our group seeks to model the molecular mechanisms with which cells respond specifically to different environmental signals. Particular emphasis is put on the regulation of gene expression by transcription factors and chromatin modifications. To this end we invoke a range of interdisciplinary approaches from data mining, data modeling and network analysis. The group profits from direct access to genome-wide data from in-house facilities, such as a deep-sequencing center.

    Applicants must have a PhD in bioinformatics or equivalent experience in a numerical science. Prior expertise with the analysis of deep-sequencing data is a plus, as is a background in statistics.

    Salaries will be based on previous experience according to TVöD guidelines. A childcare facility is directly attached to the institute. Handicapped applicants with equal qualifications will be given preferential treatment. The Max Planck Society seeks to increase the number of women in areas, where they are underrepresented, and therefore explicitly encourages women to apply.

    Candidates should send their applications (cover letter, CV, a summary of research interest, and the contact details of 2 referees) indicating the reference number 050211 via e-mail to Ms. Stallone at [email protected] or to the Max Planck Institute of Immunobiology and Epigenetics, Personnel Department, Stübeweg 51, 79108 Freiburg.

    Applications will be accepted until 15 March 2011.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Working...